Speaker illustration

Doctor Juha Koskenvuo

Turku University Hospital, Turku (Finland)

JPH2 p.(Thr161Lys) is a Finnish founder mutation associating to hypertrophic cardiomyopathy with or without systolic heart failure and conduction abnormalities

Event: ESC Congress 2018

Topic: Hypertrophic Cardiomyopathy

Session: Genetics in cardiomyopathies

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb